Studies on the volatile oils of momordica charantia l. (cucurbitaceae) and phyllanthus amarus sch. et thonn (euphorbiaceae)

Journal of Essential Oil Research

Volumn 21, Issue 5, 2009, Pages 393-399

  Moronkola, Dorcas O ^a   Ogunwande, Isiaka A ^b   Oyewole, Isaac O ^c   Başer, K Husnu Can ^d   Ozek, Temel ^d   Ozek, Gulmira ^d  

^a OLABISI ONABANJO UNIVERSITY   (Nigeria)

^b LAGOS STATE UNIVERSITY   (Nigeria)

^c BABCOCK UNIVERSITY   (Nigeria)

^d ANADOLU UNIVERSITY   (Turkey)

Author keywords

(E) 2 hexenol; (Z) 3 hexenol; Cucurbitaceae; Essential oil composition; Euphorbiaceae; Linalool; Momordica charantia; Phyllanthus amarus; Phytol

Indexed keywords

(E)-2-HEXENOL; (Z)-3-HEXENOL; CUCURBITACEAE; ESSENTIAL OIL COMPOSITION; EUPHORBIACEAE; LINALOOL; MOMORDICA CHARANTIA; PHYLLANTHUS AMARUS; PHYTOL;

ACETONE; CHROMATOGRAPHIC ANALYSIS; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; NAPHTHALENE;

ESSENTIAL OILS;

CUCUMIS SATIVUS; CUCURBITACEAE; EUPHORBIA; EUPHORBIACEAE; MOMORDICA CHARANTIA; PHYLLANTHUS AMARUS;

EID: 70349678784     PISSN: 10412905     EISSN: None     Source Type: Journal    
DOI: 10.1080/10412905.2009.9700201     Document Type: Article

References (44)

1. D.O. Moronkola, I.A. Ogunwande, T.M. Walker, W.N. Setzer and O.I. Oyewole, Identification of the main volatile compounds in the leaf and flowers ofTithonia diversifolia (Hems)Gray. J. Nat. Med., 61, 63-66 (2007).
2. A. Kar, B.K. Choudhary and N.G. Bandyopadhyay, Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats. J. Ethnopharmacol., 84, 105-108. (2003).
3. S.S. Rathi, J.K. Grover and V. Vats, The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism. Phytotherap. Res., 16, 236-243 (2002).
4. J.K. Grover, V. Vats, S.S. Rathi and R. Dawar, Traditional Indian antidiabetic plants attenuate progression of renal damage in streptozotocin induced diabetic mice. J. Ethnopharmacol., 76, 233-238 (2001).
5. T. Miura, C. Itoh, N. Iwamoto, M. Kato, M. Kawai, S.R. Park and I. Suzuki, Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice. J. Nutrit. Sci. Vitamin. (Tokyo), 47, 340-344 (2001).
6. A.P. Jayasooriya, M. Sakono, C. Yukizaki, M. Kawano, K. Yamamoto and N. Fukuda, Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterolfree and cholesterol-enriched diets. J. Ethnopharmacol., 72, 331-336 (2000).
7. A. Raman and C. Lau, Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine, 2, 349-362(1996).
8. W. Jiratchariyakul, C. Wiwat, M. Vongsakul, A. Somanabandhu, W. Leelamanit, I. Fujii, N. Suwannaroj and Y. Ebizuka, HIV inhibitor from Thai bitter gourd. Planta Med., 67, 350-353 (2001).
9. Y. Sun, P.L. Huang, J.J. Li, Y.Q. Huang, L. Zhang, P.L. Huang and S. Lee-Huang, Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi’s sarcoma associated virus. Biochem. Biophys. Res. Comm., 287, 983-994 (2001).
10. H.X. Wang and T.B. Ng, Examination of lectins, polysaccharopeptide, polysaccharide, alkaloid, coumarin and trypsin inhibitors for inhibitory activity against human immunodeficiency virus reverse transcriptase and glycohydrolases. Planta Med., 67, 669-672 (2001).
11. H.X. Wang and T.B. Ng, Studies on the anti-mitogenic, anti-phage and hypotensive effects of several ribosome inactivating proteins. Comp. Biochem. Physiol. C-Pharmacol. Toxicol., 128, 359-366 (2001).
12. E. Basch, S. Gabardi and C. Ulbricht, Bitter melon (Momordica charantia) a review of efficacy and safety. Amer. J. Health and Syst. Pharmacol., 65, 356-359 (2003).
13. H. Nagasawa, K. Watanabe and H. Inatomi, Effects of bitter melon (Momordica charantia L.) or ginger rhizome (Zingiber offifinale rose) on spontaneous mammary tumorigenesis in SHNmice. Amer. J. Chin. Med., 30, 195-205 (2002).
14. J. K. Grover and S. P. Yadav, Pharmacological actions and potential of Momordica charantia: a review. J. Ethnopharmacol., 93, 123-132 (2004) (and references therein).
15. A. Parkash, T.B. Ng and W.W. Tso, Purification and characterization of charantin, a napin-like ribosome-inactivating peptide from bitter gourd (Momordica charantia) seeds. J. Peptide Res., 59, 197-202 (2002).
16. T. Murakami, A. Emoto, H. Matsuda and M. Yoshikawa, Medicinal foodstuffs. Part XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L. Chem. Pharm. Bull. (Tokyo), 49, 54-63 (2001).
17. Y.R. Yuan, Y.N. He, J.P. Xiong and Z.X. Xia, Three-dimensional structure of beta-momorcharin at 2.55 A resolution. Acta Crystallog. Sec. D-Biol. Crystallog., 55, 1144-1151 (1999).
18. H. Xie, S. Huang, H. Deng, Z. Wu and A. Ji, Study on chemical components of Momordica charantia. Zhong Yao Cai., 21, 458-459 (1998).
19. Taylor T, The Healing Power of Rainforest Herbs, pp. 192-195, Square One Pub, Garden City Park, NY (2005) (and references cited therein).
20. G. Binder, R.A. Flath and T. R. Mon, Volatile components of bittermelon. J. Agric. Food Chem., 37, 418-420 (1989).
21. th Edn, Edit., E. Charalambus, pp. 153-160, Elsevier, Sci Publ., Amsterdam, Netherlands (1992).
22. L.N. Fernando and I.U. Gruen, Headspace-SPMEanalysis of volatiles of the ridge gourd (Luffa cylindrical and bitter gourd Momordica charantia) flowers. Flav. Fragr. J., 16, 289-293 (2001).
23. T. Ishikawa, M. Kikuchi, T. Iida, S. Seto, T. Tamura and T. Matsumoto, Steam Volatile Constituents from Seed Oils of Momordica charantia L. J. Coll. Engng. Nihon Univ, A-26, 166- 173 (1985).
24. V.B. Bharatiya, Selected medicinal plants of India. pp. 235-237, Tata Press Bombay, India (1992).
25. Nigeria Natural Medicine Development Agency [NNMDA], Medicinal Plants of Nigeria- SW/Nigeria, Vol. 1., p. 48, Federal Ministry of Science and Technology, Lagos, Nigeria (2006).
26. C. Doshi, A.B. Vaidya and D.S. Antarkar, A two-stage clinical trial of Phyllanthus amarus in hepatitis B carriers: Failure to eradicate the surface antigen. Ind. J. Gastroenterol., 13, 7-8 (1994).
27. W. Meixa, C. Haowei and L. Yanjin, Herbs of the genus Phyllanthus in the treatment of chronic hepatitis B: Observation with three preparations from different geographical sites. J. Lab. Chin. Med., 126, 350-352 (1995).
28. A. Kumaran and R.J. Karunakaran, In vitro antioxidant activities of methanol extracts of five Phyllanthus species from India. LWT - Food Sci. Technol., 40, 344-352 (2007).
29. C.A.L. Kassuya, A. Silvestre, Jr., O. Menezes-de-Lima and Ver D.M. Marotta, Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus: Evidence for interaction with platelet activating factor receptor. Eur. J. Pharmacol., 546, 182-188 (2006).
30. A.K. Kiemer, T. Hartung, C. Huber, A.M. Vollmar, L.G. Rehder and J.B. Calixto, Phyllanthus amarus has an ti-in flamma tory po ten tial by inhib ition of NOS, COX-2, and cytokines via the NF- kB pathway. J. Hep., 38, 289-297 (2003).
31. A.A. Adeneye, O.O. Amole and A.K. Adeneye, Hypoglycemic and hypocholesterolemic activities of the aqueous leaf and seed extract of Phyllanthus amarus in mice. Fitoterapia, 77, 11-514 (2006).
32. P. Kloucek, Z. Polesny, B. Svobodova, E. Vlkova and L. Kokoska, Antibacterial screening of some Peruvian medicinal plants used in Calleria District. J. Ethnopharmacol., 99, 309-312 (2005).
33. K.R. Raphael and R. Kuttan, Inhibition of experimental gastric lesion and inflammation by Phyllanthus amarus. J. Ethnopharmacol., 87, 193-197 (2003).
34. N.V. Rajeshkumar, K.L. Joy, G. Kuttan, R.S. Ramsewak, M.G. Nair and R. Kuttan, Antitumour and anticarcinogenic activity of Phyllanthus amarus extract. J. Ethnopharmacol., 81, 17-22 (2002).
35. F. Notka, G. Meier and R. Wagner, Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo. Antiviral Res., 64, 93-102 (2004).
36. PJ. Houghton, T.Z. Woldemariam, S. O’Shea and S.P. Thyagarajan, Two securinega-type alkaloids from Phyllanthus amarus. Phytochemistry, 43, 715-717 (1996).
37. L.Y. Foo, Amariin A, a di-dehydrohexahydroxydiphenoylhydrolysable tannin from Phyllanthus amarus. Phytochemistry, 33, 487-491 (1993).
38. L.Y. Foo and H. Wong, Phyllanthusiin D, an unusual hydrolysable tannin from Phyllanthus amarus. Phytochemistry, 31, 711-713 (1992).
39. A. Sharma, R.T. Singh, S.S. Handa, Estimation of phyllanthin and hypophyllanthin by high performance liquid chromatography in Phyllanthus amarus. Phytochem. Anal., 4, 226-229 (1993).
40. E. Ajaiyeoba and D. Kingston, Cytotoxicity evaluation and isolation of a chroman derivative from Phyllanthus amarus aerial part extract. Pharm. Biol., 44, 668-671 (2006).
41. E. Quijano, D. Linares and J.A. Pino, Changes in volatile compounds of fermented cereza agria /Phyllanthus acidus (L.) Skeels]. Flav. Fragr. J., 22, 392-394 (2007).
42. Y. Massada, Analysis of Essential Oils by Gas Chromatograph and Mass Spectrometry. J. Wiley & Sons, New York, NY (1976).
43. R.P. Adams, Identification of Essential Oil Components by Gas Chromatography/Mass Spectroscopy. Allured Publ. Corp., Carol Stream, IL (1995).
44. D. Joulain and W.A. Koenig, The Atlas of Spectral Data of Sesquiterpene Hydrocarbons. E-B Verlag, Hamburg, Germany (1998).